TC
BEAT

Telemus Capital’s BioTelemetry, Inc. BEAT Stock Holding History

Telemus Capital’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-10,157
Closed -$636K – 447
2019
Q1 		$636K Sell
10,157
-199
-2% -$13.7K 0.05% 244
2018
Q4 		$618K Sell
10,356
-80
-0.8% -$4.8K 0.05% 241
2018
Q3 		$673K Sell
10,436
-688
-6% -$38.4K 0.05% 260
2018
Q2 		$501K Sell
11,124
-215
-2% -$8.57K 0.04% 295
2018
Q1 		$352K Sell
11,339
-30
-0.3% -$987 0.03% 332
2017
Q4 		$340K Sell
11,369
-25
-0.2% -$724 0.03% 344
2017
Q3 		$376K Sell
11,394
-483
-4% -$16.7K 0.04% 245
2017
Q2 		$397K Buy
+11,877
New +$354K 0.04% 264

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Telemus Capital's BEAT Position: Q2 2019 in Review

Telemus Capital sold out of BioTelemetry, Inc. (BEAT) in Q2 2019, closing a stake of 10,157 shares — an estimated $636K sold.

Telemus Capital first reported a position in BEAT in Q2 2017 and held it in 8 quarters. The position peaked at $673K in Q3 2018. 251 funds tracked by Wall St. Rank hold BEAT as of Q2 2019.

  • Telemus Capital reported no remaining BioTelemetry, Inc. position as of Q2 2019 after selling out during the quarter.
  • Telemus Capital sold 10,157 BioTelemetry, Inc. shares in Q2 2019, an estimated $636K.
  • Telemus Capital first reported a position in BioTelemetry, Inc. in Q2 2017 and held it in 8 quarters.
  • Telemus Capital's BioTelemetry, Inc. position peaked at $673K in Q3 2018.
  • 251 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q2 2019.

Based on Telemus Capital's 13F filing for Q2 2019, filed 9 Aug 2019.